Identification of differentALKmutations in a pair of neuroblastoma cell lines established at diagnosis and relapse-Reference-Cited by-同舟云学术

Identification of differentALKmutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

Published:2016-11-24 Issue:52 Volume:7 Page:87301-87311
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Lindi¹,Humphreys Angharad²,Turnbull Lisa²,Bellini Angela³,Schleiermacher Gudrun³,Salwen Helen⁴,Cohn Susan L.⁴,Bown Nick²,Tweddle Deborah A.¹

Affiliation:

1. Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom

2. Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Institute of Genetic Medicine, Central Parkway, Newcastle upon Tyne, NE1 3BZ, United Kingdom

3. Institut Curie, 26 rue d’Ulm, 75248 Paris cedex 05, France

4. Department of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy;Clinical Cancer Research;2024-05-24

2. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma;Cancers;2023-10-31

3. Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies;Frontiers in Bioscience-Landmark;2023-08-17

4. The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1;OncoImmunology;2023-08-05

5. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16